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Imaging in percutaneous ablation
for atrial fibrillation
Abstract Percutaneous ablation for
electrical disconnection of the ar-
rhythmogenic foci using various
forms of energy has become a well-
established technique for treating
atrial fibrillation (AF). Success rate in
preventing recurrence of AF episodes
is high although associated with a
significant incidence of pulmonary
vein (PV) stenosis and other rare
complications. Clinical workup of AF
patients includes imaging before and
after ablative treatment using different
noninvasive and invasive techniques
such as conventional angiography,
transoesophageal and intracardiac
echocardiography, computed tomog-
raphy (CT) and magnetic resonance
imaging (MRI), which offer different
information with variable diagnostic
accuracy. Evaluation before percuta-
neous ablation involves assessment of
PVs (PV pattern, branching pattern,
orientation and ostial size) to facilitate
position and size of catheters and
reduce procedure time as well as
examining the left atrium (presence of
thrombi, dimensions and volumes).
Imaging after the percutaneous abla-
tion is important for assessment of
overall success of the procedure and
revealing potential complications.
Therefore, imaging methods enable
depiction of PVs and the anatomy of
surrounding structures essential for
preprocedural management and early
detection of PV stenosis and other
ablation-related procedures, as well as
long-term follow-up of these patients.
Keywords Atrial fibrillation .
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Introduction
Atrial fibrillation (AF) is one of the most frequently
encountered arrhythmias in the clinical settings and as such
has raised a lot of attention among scientists in evaluation
of incidence, mechanisms, consequences and treatment as
well as quality of life and cost of health care for these
patients [1, 2]. Paroxysmal and permanent AFs are
associated with an increased risk of cerebral and systemic
thromboembolic accidents, cardiac failure and mortality,
and therefore, adequate diagnosis and treatment is of major
importance. Since antiarrhythmic drugs have shown to be
of limited value, nonpharmacological treatment using
catheter ablation has been developed in the last decade
for selected patients. Most arrhythmogenic foci in patients
with AF refractory to medical therapy are located within
pulmonary veins (PVs) [3]. Discovery by Haissaguerre et
al. of the importance of radiofrequency catheter ablation in
PVs that can eliminate AF by electrical disconnection of
arrthymogenic foci represented a major therapeutic ad-
vance, which has prevented recurrence of AF in 70–80% of
patients during the first year of follow-up [4, 5]. However,
radiofrequency ablation in the vicinity of the ostia is
associated with significant incidence of stenosis after the
procedure and during short- and long-term follow-up [6, 7].
Although usually asymptomatic, PV stenosis could
progress to complete occlusion, which could cause
segmental pulmonary hypertension, venous infarction of
the corresponding lobe or even a fatal outcome [8–10].
Several imaging modalities are being used to depict PV
anatomy and the left atrium, such as conventional pulmo-
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[12], intracardiac ultrasound [13], spiral and multidetector-
row computed tomography (MDCT) [14, 15], and mag-
netic resonance imaging (MRI) [16].
Clinical considerations
Atrial fibrillation
The prevalence of AF has been estimated to be 0.4% in the
general population, but due to replacement of the muscle
with fibrotic tissue at the rate of 1% each year after the age
of 50, it increases to about 5% in patients over 65 years
[17]. Focal arrhythmogenic triggers may be found in the
superior vena cava, crista terminalis, coronary sinus, vein
of Marchall (v. obliqua atrii sinistri - Marshalli), interatrial
septum or left atrial posterior wall, but several studies have
suggested that most AFs are related to the existence of
arrhythmogenic foci in PVs [18, 19]. The study by Jais et
al. [20] demonstrated that PVs in patients with AF have
distinctive electrophysiological properties, which could be
explained by extension of atrial myocardium in the veins.
The atrial myocardial sleeves have different lengths, 10–
20 mm in the superior veins and 5–10 mm in the inferior
PVs, and are the thickest in the inferior wall of the superior
veins and superior wall of the inferior veins, thinning out or
disappearing as the veins divide into segmental branches
[21]. In addition to this, dilatation of the venous orifices
presumably stretches the myocardium, thus changing its
electrophysiological characteristics [22].
Antiarrhythmic drugs have shown inadequate efficacy
and can paradoxically lead to life-threatening arrhythmias,
and therefore, other therapeutic options have been
considered, such as application of implantable devices
and ablation therapy. In the last 15 years, percutaneous
catheter ablation techniques have become a preferred
therapeutic option in patients with paroxysmal AF who do
not respond to at least 1–2 antiarrhythmic drugs, but future
technical improvements will possibly widen the clinical
spectrum for ablative treatment [23].
Radiofrequency ablation
Radiofrequency ablation is performed by using an electric
current with alternating frequencies that creates myocardial
lesions (Fig. 1). Different ablative techniques have been
developed with various clinical efficacy and safety, such as
focal ablation within PVs, segmental ablation and applica-
tion of circumferential lesions. Successful PV isolation is
reached in 89–97% of patients and is associated with a risk
of PV stenosis in up to 42% of patients after the procedure
and during the follow-up period [24, 25]. Frequency of PV
stenosis depends on the technique and method of
assessment, but overall major complication rate in high-
volume electrophysiology laboratories is acceptably low
and varies between 1% and 2% [4, 26].
Cryothermal ablation and other techniques
Cryothermal energy ablation is a relatively new technique
for treatment of AF that preserves the basic underlying
tissue architecture and integrity of the endocardial structure
and therefore produces less risk of thrombus formation
[27]. Long-term follow-up studies have shown the proce-
dure is not associated with PV stenosis and stroke although
clinical outcome is controversial and has not fulfilled initial
high expectations [28–30]. Ultrasound [31], microwave
[32] and diode laser ablation are alternative procedures and
are undergoing preclinical and clinical evaluation, with
great potential in clinical application.
Imaging
Detailed anatomical considerations of PVs and the left
atrium are very important for effectiveness of PV ablation
and clinical success of the procedure. The technique has
been increasingly performed in electrophysiology labora-
tories, and therefore, radiologists are encountering more
requests to assess anatomy of PVs and the left atrium both
before and after the procedure.
Fig. 1 Catheters for percutane-
ous ablation. a Lasso and abla-
tion catheter; b circumferential
catheter is positioned for map-
ping in left superior pulmonary
vein through separate transseptal
access (pulmonary venography).
LSPV left superior pulmonary




Percutaneous ablation is based on complete electrical
disconnection of PVs from atrial tissue, and detailed
morphological information of PVs, including their relation-
ship with the left atrium, are essential as the anatomic
roadmap for the procedure [33]. Comprehensive knowl-
edge of PV anatomy before the procedure allows size
selection and positioning of mapping/ablation catheters
and reduces overall procedure and radiation time. Also,
preprocedural imaging includes measurement of PV ostial
diameter, a mandatory parameter for assessment of poten-
tial postprocedural PVs stenosis. Different imaging
modalities have been used for assessment of PVs.
Conventional angiography is an invasive method that
exposes a patient to radiation although it does not add
invasiveness to the whole procedure in this particular case.
Furthermore, it requires iodine contrast and does not allow
detailed visualisation of all PVs due to structure overlap.
Transoesophageal echocardiography frequently omits de-
tailed visualisation of the left inferior PV [34] but is
accurate in diagnosing small-branch stenosis, which
produces a high velocity Doppler jet [35]. Intracardiac
echocardiography provides real-time imaging of the inter-
atrial septum and the proximal 1–3 cm of PVs, facilitating
catheter guidance and accurate stent placement, but is not
instructive for visualisation of the PV/left atrium relation-
ship [36, 37]. Measurements of PV flow velocity could be
obtained by both transoesophageal and intracardiac
Doppler echocardiography, but these are less specific
than direct measurements by conventional PVangiography
[37] (Fig. 2). Conventional angiography overestimates
while transoesophageal echocardiography underestimates
PV ostial diameter compared with CT or intracardiac
echocardiography [37].
CT and, recently, MDCT and MR angiography (MRA)
have been applied to imaging PVs, with excellent spatial
resolution. These techniques have low interobserver and
intraobserver variability and provide accurate imaging of
PVs and left atrial anatomy [38]. The major advantage of
these methods is measurement of lumen diameter and
visualisation of not only superior and inferior, but also
anterior and posterior walls of the PVs. Reconstructions of
the acquired images could be performed in three planes
(transversal, sagittal and coronal) using different postpro-
cessing techniques of the very thin axial slices as maximum
intensity projection (MIP) and multiplanar reformation.
Improved three-dimensional (3D) volume-rendering tech-
nique enables panoramic visualisation of PV anatomy and
assessment of anatomical relationships of PVs and
neighbouring structures. Virtual flythrough endoscopic
images can also be reconstructed, allowing endoluminal
evaluation of the venoatrial junction and PV branches.
Furthermore, CT and 3D MRI morphological information
has been used for stereotactic guidance during anatomi-
cally targeted ablations as well as to navigate and stabilise
an ablation catheter [39, 40].
In comparison with MRI, MDCT scanning is fast, is
completed during one breath hold in 20 s, is easy to
perform and is well tolerated. However, CT and MDCT
exposes patients to considerable amounts of radiation, 3.1–
4.1 mSy, which is a dose that is likely to cause one fatal
radiation-induced cancer every 1,240–1,640 examinations
[41]. This calculation was based on estimated carcinogenic
risk of 0.0004 per 1 mSy according to the International
Commission on Radiological Protection [42]. MDCT with
electrocardiogram (ECG) gating techniques exposes a
patient to radiation of approximately 8 mSv [43].
Furthermore, MDCT could miss significant information
and requires 100 ml of potentially nephrotoxic iodine
contrast [44]. A bolus test or bolus tracking with triggering
could be used to reduce the amount of contrast media [46]
although it may not be absolutely necessary for analysing
PV anatomy [45].
Image acquisition using MRI is ECG gated, with breath
hold for about 10 s. After the correct image planes are
defined, fast-precession steady-state sequence (True-FISP)
images can be obtained for anatomical and functional
assessment of PVs. For 3D MRA, nongated FISP sequence
Fig. 2 Normal pulmonary vein. Doppler flow image of the left
upper pulmonary vein shows no stenosis of the vein
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is applied in a paracoronal orientation, and after injection of
contrast agent (0.1 mmol/l per kilogram of body weight,
flow 3ml/s) followed by a 20ml saline solution (flow 3ml/s),
angiogram-like images are acquired. The contrast media
bolus should be targeted for peak enhancement in the left
atrium, as determined by a bolus test timing sequence.
Thus, the use of MRI is not associated with radiation and
application of potentially nephrotoxic iodine contrast, can
quantify PV flow and is considered as a method of choice
in patients without absolute contraindications, such as in
electronically, magnetically, and mechanically activated
implants (automatic cardioverter defibrillators, cardiac
pacemakers, metallic splinters in the eye, ferromagnetic
haemostatic clips in the central nervous system).
Anatomy of pulmonary veins
Pulmonary vein patterns The basic pattern of PVs with
two ostia to the left and two ostia to the right has been seen
with different frequency in reported studies, ranging from
57% [37, 47] to 80% of the examined population (Fig. 3),
[48]. This diversity of findings may be due to lack of
definition of PV ostium and different imaging techniques
used [38].
An additional venous orifice could be a source of
arrhythmogenic foci or share an orifice with a short main
venous stem and therefore needs to be ablated [49, 50]. In
general, the right PVs were found to be more divergent
than left ones. The right middle PV tends frequently to be
the source of atrial arrhythmias although no significant
Fig. 3 Normal anatomy of pulmonary veins (PVs) as shown using
contrast-enhanced multidetector-row computed tomography
(MDCT) images. Separate insertion of left inferior PV in coronal,
axial and sagittal plane (from left to right panel). Volume rendering
reconstruction of the heart and PVs in the posterior view (b), and
virtual endoscopy view of the left atrium visualising the origin of all
PVs (c). LSPV left superior pulmonary vein, LIPV left inferior
pulmonary vein, RSPV right superior pulmonary vein, RIPV right
inferior pulmonary vein, LA left atrium, LV left ventricle
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association between particular venous pattern and atrial
arrhythmias has been proven [44]. Frequent presence of
the right middle vein may be explained by the necessity to
drain the lung area between the divergent right superior
and right inferior PV [37]. Based on MRI studies, single
right middle PV has been found in 4–27% of patients [37,
51], (Fig. 4) while two additional right PVs are less
frequent and have been reported in 3–7% of the population
[47, 51]. This vein provides sufficient blood flow if
postablation stenosis of the right inferior PV occurs.
Furthermore, since the ridge of atrial tissue separating the
veins is narrow, unstable position of the ablation catheter
in this area could potentially result in adverse application
of energy inside one of the veins [37].
Fig. 5 Common trunk of the left superior and left inferior
pulmonary vein. The superior and inferior left pulmonary veins
have merged before entering the left atrium. a Lines on the left panel
in coronal projection indicate position of slices in the sagittal plane
presented in the middle and right panels. Arrowhead in the middle
panel is pointing to the common trunk. b Volume rendering
technique reconstruction of multidetector-row computed tomogra-
phy (MDCT) images from posterior view. The arrow is indicating
the common trunk. LSPV left superior pulmonary vein, LIPV left
inferior pulmonary vein, LA left atrium, LV left ventricle
Fig. 4 Right middle pulmonary
vein. Pulmonary venography
(a) and volume rendering
technique reconstruction
(b) of images obtained using
contrast-enhanced multidetec-
tor-row computed tomography
(MDCT). Right middle pulmo-
nary vein is seen as a separate
additional vein
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Right top PV, reported in the MRI study of Lickfett et
al. [51] in 3% of the patients, drains the right upper lung
lobe, presumably the bronchopulmonary segment as well.
It is too small (7±2 mm) to be a source of AF, but it should
be recognised during the intraprocedural venography if it
is accidentally blocked with the angiography catheter.
Additional single left-sided PV, draining the lingula, was
found in only 2% of the patients in the MRI study of
Mansour et al. [38]. Common ostium is a confluence of
PVs before entering the left atrium (Fig. 5). Right-sided
single venous ostium was found in 2–39% of the cases
[38, 49] while the left-sided single ostium was reported in
3–83% of patients with AF [46, 47, 52, 53]. This
difference could be related to both definition of the
common ostium and sensitivity of the applied imaging
technique. In the study of Jongbloed et al., right-sided
common ostia were observed in 31% with MDCT and in
38% with intracardiac echocardiography while left-sided
common ostia were identified in 79% and in 74%,
respectively [52].
Branching pattern Both cross-sectional imaging techniques,
MDCT and MRI, have been extensively used in evaluation
of PV branching pattern. Early PV branching was defined
as either branching within 1 cm of PV bifurcation or
within 5 mm from the ostium of the main PV [37, 52] and is
often prone to stenosis. Early branching in theMRI study of
Mansour et al. [38] was detected in 41% of patients and was
more frequent in right-sided PVs, supported by the study of
Jongbloed et al. using MDCT [52]. This study showed that
MDCT sensitivity for detecting an early branching pattern
of right PVs was 54% in comparison with intracardiac
echocardiography. Topographic assessment of PVs, includ-
ing second-order branches, could be successfully per-
formed using MRI fly-through endoscopic navigation,
which, although complex and time consuming, holds
promise for the wider application [47, 51, 54].
Pulmonary vein orientation Different PVorientation to the
left atrium might explain the difficulties in proper catheter
placement [38]. MRI and MDCT have been very useful in
presenting PV orientation in relation to different planes.
The study of Ho et al. on 20 human heart specimens [55]
revealed that superior veins enter the left atrium at an
angle of 45–60° to the horizontal plane and inferior veins
at an angle of 30–45°. The MRI study of Mansour et al.
showed that the right superior PV was projected at 131±
11° in relation to the longitudinal plane of the left atrium,
right inferior PV at 206±16°, left superior at 32±13° and
left inferior PV at 329±14° [38].
Fig. 7 Early stenosis of left
superior pulmonary vein. Left
superior pulmonary vein before
(a) and after (b) radiofrequency
ablation (arrow). Stenosis is
remarkable immediately after
the procedure on control pul-
monary venography. LSPV left
superior pulmonary vein, LIPV
left inferior pulmonary vein
Fig. 6 Fatty tissue. Fatty tissue
is seen as a radiolucent area
between the posterior wall of the
left atrium and anterior wall of
oesophagus on axial multide-
tector-row computed tomogra-
phy (MDCT) image (a). No
fatty tissue could be seen in
another patient (b)
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Pulmonary vein ostia PVostium is defined as the distance
between the upper and lower wall of the PV and the wall
of adjacent left atrium [38, 52]. In preprocedural imaging,
PV ostial diameter is an important factor in selection of
optimal catheter size while after the procedure, a possible
stenosis is a major concern. In addition, small PV ostial
diameter (less than 10 mm) is more frequently prone to
stenosis, and most operators avoid ablation of these veins.
However, they may have a focal AF trigger or may be
connected by muscle sleeves to another vein, and there-
fore, they needed to be electrically isolated [38].
Normal PV ostial diameter measurements depend on
imaging plane and technique and cardiac cycle. Cross-
sectional anatomy does not reflect true anatomic variations
of PVs, and the sagittal plane is suggested as more
reproducible for serial measurements [56]. Also, venog-
raphy overestimates and transoesophageal echocardiogra-
phy underestimates ostial diameter compared with CT and
intracardiac echocardiography while MDCT and intracar-
diac echocardiography provide comparable measurements
of PV ostia [36, 52]. Furthermore, in atrial systole, PV
ostial size decreases by 32.5%, indicating the need for PV
measurements in the same phase of the cardiac cycle [57].
Ostia of the superior PVs in patients with AF were
larger than in healthy controls or in non-AF patients [53,
58–60]. Patients with persistent AF had larger ostia than
patients with paroxysmal AF [53], which has not been
confirmed in other studies [47, 60, 61]. Superoinferior
diameter of PV ostia is longer than anteroposterior, and
therefore, the venous ostial index calculated as their ratio
has been suggested for evaluation of PVostia [15, 52, 62].
Value of the ostial index indicates oval shape of left-sided
and round shape of right-sided PVs [52, 62].
Anatomy of the left atrium
Preprocedural evaluation of patients with AF includes
assessment of the left atrium for the presence of thrombus,
left atrial dimensions and volumes, relationship with
adjacent structures and imaging of left atrial appendage.
Exclusion of atrial and left atrial appendage thrombi is
essential since it is an absolute contraindication for
ablation [63].
In healthy volunteers, the mean longitudinal diameter of
the left atrium is 4.5±1.4 cm, the transverse dimension is
4.0±1.2 cm [51] while the volume varies from 79 to 115 ml
Fig. 9 Stenosis of the left inferior pulmonary vein. Multiplanar
reconstruction of magnetic resonance angiography (MRA) 1 day
after radiofrequency ablation (a), 3 months after the procedure (b)
and after 6 months’ follow-up (c). After 3 months’ follow-up,
pulmonary vein diameter at the ostium was reduced by 25% while
after 6 months the vein diameter was reduced by 50% (arrows)
Fig. 8 Occlusion of the left
superior pulmonary vein. Maxi-
mal intensity projection of
magnetic resonance angiogra-
phy (MRA) in axial (a) and
coronal (b) orientation showing
total occlusion of the vein
(arrow). LSPV left superior
pulmonary vein, LA left atrium
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to 65 to 139 ml, depending on the technique applied,
echocardiography or cardiac MRI [17, 61, 64]. Patients
with idiopathic AF have longer longitudinal diameter
compared with healthy controls [17, 65].
Another critical clinical issue is the relation of the
posterior wall of the left atrium and the oesophagus
because the known complication of catheter ablation could
be atrioesophageal fistula [66]. As measured on helical CT,
posterior wall of the left atrium is 2.2±0.9 mm while the
anterior aspect of the oesophageal wall is 3.6±1.7 mm.
Fatty tissue between these structures is 0.9±0.2 mm, which
might insulate the oesophagus from thermal injury during
radiofrequency ablation and could explain relatively low
incidence of atrioesophageal fistula (Fig. 6). However, the
fatty tissue layer is discontinuous in 98% of patients and is
usually absent at the level of the mid posterior wall in
average length of 18±10 mm (3–40 mm) [67].
Left atrial appendage could be assessed using different
modalities: MDCT, MRI, echocardiography. Functional
assessment using intracardiac echocardiography has been
Fig. 10 Thrombosis of the left superior pulmonary vein (PV). The
patient underwent ablation of the left superior PV and had
hemoptysis and chest discomfort during 3 months’ follow-up.
a Chest X-ray shows heterogeneous opacity in the left upper lobe.
b, c Axial contrast-enhanced computed tomography (CT) images
(lung window) demonstrate ground-glass attenuation and focal periph-
eral consolidation in the left upper lobe (white arrows in b and c),
thickened interlobular septum (black arrows in c) consistent with
pulmonary venous infarction. Note also pleural effusion (arrowheads
in b). d Axial contrast-enhanced CT scan (mediastinal window)
presents occlusion of the left superior PV (open arrow) with soft
tissue attenuation surrounding the expected location of the vein.
Contrast is seen in the right superior pulmonary vein (curved arrow).
Reproduced with permission from American Journal of Roentgen-
ology, Ravenel JG, Duke University Medical Center, Durham, NC,
USA 8
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shown to be valuable in evaluation of left atrial appendage
emptying velocities and was found to be a predictor of
recovery of atrial booster pump function [63].
Postprocedural imaging
Imaging after ablation includes evaluation of PVs, left
atrium and other structures prone to complications. Due to
the increasing frequency of ablation procedures, radiolo-
gists should be aware of timing and severity of potential
complications and their clinical implications. The most
commonly reported complication after radiofrequency
ablation is PV stenosis while others have been documented
less frequently.
There is no overall accepted consensus on timing of
imaging after the procedure. Usually, patients are imaged
1 day after the procedure, and then after 1, 3, 6 and
12 months, depending on study design and clinical
indications [6, 63, 68]. This enables monitoring of PVs
and left atrium and possible dynamics of PV narrowing. PV
diameter reduction of less than 50% usually remains stable
while narrowing of more than 50% after 3 months tends to
progress to high-grade stenosis [68]. These results
demonstrate the need for follow-up imaging even in
asymptomatic patients who could develop symptoms that
might be misinterpreted. Also, in a case of symptom
recurrence, initial information of PV stenosis is important
for planning reintervention.
Various methods have been used to screen for the
presence of postprocedural complications. Keeping in
mind noninvasiveness, scanning with MDCT and MRI
are recommended imaging modalities. However, MDCT
scanning exposes a patient to repeated radiation and
application of a contrast media. In addition to previously
mentioned advantages, MRI could quantify PV flow while
MR pulmonary perfusion imaging has reached sensitivity
of 95.2% in revealing pulmonary perfusion defect in
comparison with single-photon emission CT [69]. There-
fore, MRI seems to be the preferred imaging technique for
follow-up.
Evaluation of the pulmonary veins
The incidence of PV stenosis after radiofrequency ablation
varies depending on imaging modality applied, ablation
techniques and energy delivered during the procedure [70].
Fig. 11 Magnetic resonance imaging (MRI) perfusion study. MR perfusion images of patients with occlusion of the left superior pulmonary
vein from Fig. 8. Axial plane MRI images from the pulmonary apex to the base show corresponding perfusion defects thorough the left lung
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Furthermore, sensitivity of various diagnostic methods is
largely variable, without widely accepted criteria for PV
stenosis [35, 43].
The frequency of PV stenosis reported in the literature
varies between 1–42% [1, 7]. Interestingly enough, the
high incidence of PV stenosis reported by Chen (42%) was
based on transoesophageal echocardiography flow velocity
and is considered to overestimate the incidence of this
complication [7]. A later study by the same group with the
same technique revealed stenosis in 33% [12] of the
patients while other groups reported far lower incidence of
this complication [19, 33, 71].
After the procedure, PV wall thickness significantly
increases while the diameter is considerably reduced due to
inflammatory oedema [72], as confirmed by increased PV
ostial flow on intracardiac Doppler echocardiography,
(Fig. 7). Although this morphological changes did not
predict subsequent PV stenosis [73], diameter reduction of
more than 25% was reported as an independent long-term
predictor of severe stenosis (Fig. 8), [74]. Left inferior PV
more frequently tends to develop stenosis due to its smaller
size, which often causes longer operative manipulation
[68] (Fig. 9).
Pulmonary hypertension is caused by significant steno-
sis or occlusions of one or more PVs. This complication is
often latent at rest but manifests during exercise [75], and it
could be identified by transoesophageal echocardiography.
Transthoracic echocardiography has lower diagnostic ac-
curacy and has not been routinely used in visualisation of
PVs and PV stenosis because it usually allows evaluation
of the proximal part of the right upper pulmonary vein only.
Morphological alterations include septal thickening,
ground-glass opacity and interlobar septal thickening and
could be seen on CT. In addition, reactive regional
mediastinal lymph node enlargement may be demonstrated.
Perfusion defects in the area of affected PVs could be
verified by ventilation-perfusion scans or MRI perfusion
study [76] (Fig. 10). In the study of Kluge et al., pulmonary
perfusion partially recovered over weeks, but complete
normalisation was observed in only 17% of patients [69].
PV thrombosis and infarction (Fig. 11) are rare but
clinically important complications, occurring 1 day to
3 months after radiofrequency ablation. This complication
may be presented on chest X-ray as an area of focal
pulmonary oedema distal to the occluded vein while CT
may show nodules and wedge-shaped parenchymal con-
solidation. PV dissection is a serious but infrequent
complication [77]. Fatal outcome is rarely described, as
in the case study of Nilsson et al., who reported ominous
postprocedural course with alveolar damage, disseminated
intravascular coagulation, multiple thrombi formation and
haemorrhagic infarctions [9].
Mild or moderate PV stenosis or stenosis of a single vein
is often asymptomatic [73]. Asymptomatic patients might
require follow-up, with MRI technique as a method of
choice due to its advantages over other methods. Even if
symptoms are present, they could appear to be of
respiratory origin and could improve spontaneously over
time in a significant number of patients [73]. However, in
patients with PV stenosis who experience persistent cough,
perfusion defects and documented PV diameter less than
6 mm, treatments of choice are balloon dilatation or
stenting [74, 78] (Fig. 12). These procedures offer imme-
diate symptoms relief, observed usually within 1 hour.
However, in up to 47% of patients, in-stent or in-segment
restenosis can develop, caused by neointimal hyperplasia,
fibrosis and thrombus formation [79].
Evaluation of the left atrium
In patients with restored sinus rhythm, left atrial size
decreases while progressive left atrial dilatation was
associated with late recurrence of AF [71]. Furthermore,
Fig. 12 Stents on left superior and left inferior pulmonary veins
(PVs). Maximum intensity projection of multidetector-row com-
puted tomography (MDCT) images in oblique axial (a) and coronal
(b) projection and volume rendering technique reconstruction,
posterior view (c), of PVs after MDCT angiography depicts stents
of the left veins due to progressive diameter reduction, which
resulted in complete occlusion after 6 months’ follow-up. Arrow in
c indicates the right middle pulmonary vein. LSPV left superior
pulmonary vein, LIPV left inferior pulmonary vein, LA left atrium
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thermal injury of the posterior wall of the left atrium and
oesophagus during radiofrequency ablation bear a risk of
oesophageal perforation and subsequent atrial–oesopha-
geal fistula. This complication, the incidence of which is
not reported in the literature, is caused by overlapping of
ablation lines of the posterior wall of the left atrium and
anterior wall of the oesophagus [80]. However, in patients
who underwent intraoperative radiofrequency ablation of
AF [81], it is described in 1%, with 50% mortality [82].
Evaluation of other structures
Embolic complications can occur up to 3 months after the
procedure at the rate of 2% despite anticoagulant therapy
[83]. Other complications include pericarditis (3–4.8%),
cardiac perforation (hemopericardium, tamponade, hemo-
thorax), valvular injury, pleural effusion and complications
not directly related to the ablation procedure itself (hemo-
pneumothorax, catheter -site haematoma, arteriovenous
fistula) [84].
Conclusions
Percutaneous catheter ablation techniques using different
energy sources have become frequently applied therapeutic
options in many electrophysiological laboratories world
wide. Comprehensive morphological information of PVs
(PV pattern, branching pattern, orientation, size of the
ostia), their relationship with the left atrium and assessment
of the left atrium for the presence of thrombus, measure-
ments of left atrial dimensions and volumes and imaging of
left atrial appendage are essential elements in preprocedur-
al imaging as a roadmap for the ablation. Noninvasive and
invasive imaging modalities, such as conventional angi-
ography, transoesophageal and intracardiac echocardiog-
raphy, CT, MDCT and MRI have been used to provide
preablation information, with different diagnostic accuracy.
This information is important for appropriate sizing of a
catheter and visualisation of all PVs and the left atrium. CT,
MDCT and MRA have been proven to be valuable,
noninvasive diagnostic tools in imaging PVs and the left
atrium, with good temporal and spatial resolution and
excellent interobserver and intraobserver agreement.
Furthermore, MRI does not expose patients to radiation
and application of potentially nephrotoxic iodine contrast
and can quantify PV flow and perform pulmonary
perfusion study, and it is therefore considered as a method
of choice in patients without contraindications. During the
follow-up period, imaging techniques enable assessment of
postprocedural remodelling of PVs and the left atrium and
procedure-related complications. Since repeated examina-
tions are necessary after the procedure, the noninvasive
methods of MDCT and MRI are preferred imaging
modalities. Therefore, imaging methods are an indispens-
able part of the complete clinical workup of patients with
AF that minimise risk for development of complications
and are potentially leading to greater acceptance for
ablation procedures.
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